)
Edge20 Mar 2026
Tetra Pak: The Shape of Innovation
The story of Tetra Pak, the Rausing family, and how a paper tetrahedron gave rise to a company that now delivers almost 180 billion packages a year.
CHINA NATIONAL MEDICINES CORP
CHINA NATIONAL MEDICINES CORP (600511) investor relations material
CHINA NATIONAL MEDICINES CORP Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary20 Mar, 2026
Executive summary
Maintained stable growth in core businesses, focusing on pharmaceutical and medical device distribution, with leading market share in Beijing and continued expansion in innovative and digital services.
Adapted to industry transformation driven by policy, market restructuring, and technology, emphasizing compliance, supply chain optimization, and value-driven growth.
Financial highlights
Achieved revenue of ¥52.47 billion in 2025, up 3.70% year-over-year; total profit was ¥2.60 billion, down 2.01%.
Net profit attributable to shareholders was ¥1.997 billion, a slight decrease of 0.18% year-over-year.
Operating cash flow reached ¥2.01 billion, up 20.88% from the previous year.
Total assets at year-end were ¥36.69 billion, with shareholders’ equity of ¥18.54 billion.
Proposed cash dividend of ¥8 per 10 shares, totaling ¥603.6 million, pending shareholder approval.
Outlook and guidance
Industry expected to see continued compliance upgrades, digital transformation, and increased market concentration.
Long-term growth drivers include aging population, rising healthcare spending, and demand for specialized medicines and health management.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from CHINA NATIONAL MEDICINES CORP
- Revenue up 1.81%, net profit down 6.80%, with strong market share and digital transformation.600511
Q4 202418 Dec 2025 - Q3 profit and EPS rose over 13% year-over-year, but operating cash flow stayed negative.600511Q3 202522 Oct 2025
- Revenue up 3.54% but net profit down 5.19% amid industry reform and strong distribution.600511Q2 202521 Aug 2025
- Revenue and net profit rose modestly, but operating cash flow turned negative.600511Q3 202413 Jun 2025
- Revenue and net profit grew modestly, with stable distribution but industrial headwinds.600511Q2 202413 Jun 2025
- Revenue up 4.87% in Q1 2025, but net profit and ROE slightly declined.600511Q1 20256 Jun 2025
Next CHINA NATIONAL MEDICINES CORP earnings date
Q1 202624 Apr, 2026
CHINA NATIONAL MEDICINES CORP
Next CHINA NATIONAL MEDICINES CORP earnings date
Q1 202624 Apr, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage